Health Reference LibraryRiboflavin 5-phosphate (R5P): active vitamin B2 and when to choose it
This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Summary
R5P is vitamin B2 already converted into its coenzyme form, the direct precursor of FMN and FAD, which drive mitochondrial energy production, glutathione recycling and the MTHFR enzyme that activates folate. Requirements are small at 1.3mg daily for men and 1.1mg for women, and riboflavin has no established upper intake level because harm has not been demonstrated at high doses. One honest boundary matters here. The migraine prevention evidence, including the Schoenen randomised trial, used 400mg daily of standard riboflavin for three months, and at 47.5mg per capsule this product sits well below that research dose, so choose R5P for cofactor sufficiency and methylation support rather than as a migraine protocol.
How it works
Riboflavin becomes useful only as flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), the two flavocoenzymes built from that vitamin. FMN and FAD carry electrons in the mitochondrial respiratory chain, recycle oxidised glutathione back to its active form via glutathione reductase, and power the MTHFR enzyme that converts folate into methylfolate. R5P is riboflavin with the first phosphorylation step already done, so the body holds the coenzyme precursor directly rather than converting from scratch.
Effective dose
The adult requirement is 1.3mg daily for men and 1.1mg for women per the NIH Office of Dietary Supplements, so a 47.5mg R5P capsule covers daily needs many times over and one capsule is a full maintenance dose. The migraine research dose is different territory entirely. Trials used 200 to 400mg of standard riboflavin daily, and reaching 400mg with this capsule would take more than eight capsules a day, which is not what this product is designed for. Anyone pursuing the migraine protocol should discuss high-dose standard riboflavin with a GP or pharmacist.
Forms compared
Each capsule provides 47.5mg of vitamin B2 as riboflavin 5-phosphate in a vegetarian capsule shell, made in the UK, with R5P as the sole B2 form. Riboflavin is light sensitive, so keep the pot closed and out of direct light. A liquid R5P option exists for smaller adjustable doses. Standard riboflavin is cheaper per milligram and is the form the migraine trials used, so form choice should follow purpose.
Timing
B2 is water soluble and absorbed best in moderate amounts with food. Morning or midday with a meal is a sensible default, partly because B2 turns urine bright yellow within hours, which is harmless and simply shows absorption. If you also take methylfolate or B12 for methylation support, taking the three together at the same meal keeps the pathway supplied at once.
Safety profile
Riboflavin has no established tolerable upper intake level because the evidence on adverse effects is insufficient to set one, per the NIH ODS and the underlying US dietary reference intake review. The bright yellow urine at supplemental doses is expected and harmless. In the 1998 randomised migraine trial at 400mg daily, adverse events were minor, with single cases of diarrhoea and increased urination. Persistent headaches that are worsening, changing in character or accompanied by neurological symptoms need a GP, not a supplement.
Special populations
People with MTHFR variants have a specific reason to care about B2 status, because the MTHFR enzyme is FAD-dependent and adequate riboflavin supports whatever conversion capacity that enzyme has. The NIH ODS notes deficiency risk rises with thyroid hormone insufficiency, alcohol dependence and some chronic illnesses. Pregnancy and breastfeeding raise the requirement modestly, to roughly 1.4 and 1.6mg daily, which normal diet plus any standard supplement covers comfortably.
Interactions
Riboflavin has few meaningful drug interactions at nutritional doses. Some anticholinergic drugs and long-term phenobarbital may alter riboflavin handling, which matters only at the margins of a poor diet. High-dose riboflavin can interfere with some urine-based lab measurements because of its colour. Nutri365 checks for interactions and contraindications across the whole supplement and lifestyle picture when you use the platform.
Guideline positions
The NIH Office of Dietary Supplements (2025) sets the adult RDA at 1.3mg for men and 1.1mg for women, records that no upper intake level exists, and summarises the migraine evidence. Schoenen and colleagues (Neurology, 1998) randomised 55 adults to 400mg riboflavin or placebo for three months; attack frequency fell significantly (p=0.005), 59 percent of the riboflavin group improved by at least half versus 15 percent on placebo, and one additional responder was gained for every 2.3 people supplemented. A 2017 systematic review classified that trial as Class I evidence.
Practical framework
Choose R5P when the aim is reliable B2 cofactor status, particularly alongside methylfolate and B12 in a methylation-focused approach, or where energy metabolism support is the goal at sensible doses. Vitamin B2 R5P Capsules provide 47.5mg of riboflavin 5-phosphate per capsule at £20.93 for the bottle, in stock and UK-made, at nutritailor.co.uk/products/vitamin-b2-r5p-capsules. For the 400mg migraine protocol, standard riboflavin is the studied form and a GP or pharmacist conversation is the right first step.
Common misconceptions
R5P is often marketed as better absorbed than standard riboflavin, but intestinal phosphatases largely convert R5P back to riboflavin before uptake, so the practical case for R5P is supplying the coenzyme precursor rather than superior absorption. Another misconception is that a small R5P dose carries the migraine evidence; the trials used 400mg of standard riboflavin, roughly eight times this capsule. Finally, bright yellow urine is frequently read as wasted supplement, when that colour simply reflects riboflavin excretion after absorption of what the body can use.
Sources
- NIH Office of Dietary Supplements 2025. Riboflavin Fact Sheet for Health Professionals. NIH ODS.
- Schoenen J, Jacquy J, Lenaerts M 1998. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466-470.
- Thompson DF, Saluja HS 2017. Prophylaxis of migraine headaches with riboflavin: a systematic review. J Clin Pharm Ther.
- Institute of Medicine 1998. Riboflavin, in Dietary Reference Intakes (IOM). National Academies Press.